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ABSTRACT
Introduction: The objective of preventing
surgical scar formation is to improve the
quality of life for patients. Many medical
products have been used in preventing
hypertrophic scarring but an optimal
treatment method has not been established
yet. At the present, there are several studies
demonstrating the potential of herbs in scar
prevention. The purpose of this study was to
evaluate the efficacy of combined herbal
extracts gel (CHG) in the prevention of
surgical scar formation.
Methods: All the patients who underwent
bilaterally symmetric surgical procedures were
selected using inclusion and exclusion criteria
and were then treated with both the CHG (CHG
group) and placebo gel. Each gel was applied on
separate scars twice daily for 12 weeks. The scars
were photographed and evaluated using Patient
and Observer Scar Assessment Scale (PSAS and
OSAS, respectively).
Results: The CHG-treated scars showed lower
median PSAS scores than the placebo group in
color, stiffness, thickness, irregularity, and
overall scores, with statistically significant
difference at 12 weeks. For OSAS, the scars in
the CHG group showed lower median scores
than the placebo group in pigmentation,
thickness, and overall scores at 12 weeks. The
median OSAS scores in vascularity, relief, and
pliability differed from placebo group and were
statistically significant at 8 weeks. No side
effects were observed in either group.
Conclusion: The CHG might be effective in the
prevention of surgical scarring.
Keywords: Aesthetic dermatology; Combined
herbal extract gel; Herbal extracts; Hypertrophic
scar; Surgical scar; Silicone; Quality of life
INTRODUCTION
Hypertrophic scarring is caused by an imbalance
between extracellular matrix (ECM) protein
deposition and degradation [1]. There are many
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factors affecting surgical scarring such as healing
of the wounds, tension, and the line of the scars.
Prolonged redness and post-inflammatory
pigmentation of the scar tissues cause patients
to be concerned about the noticeability of
scars, especially in aesthetic surgery such as
lower blepharoplasty, face-lift, or breast
augmentation. Apart from the use of advanced
wound dressing products to accelerate wound
healing, many methods are used to prevent scar
formation. Pressure garments, taping, and
silicone gel have been prescribed for scar
prevention [2]; however, these methods
have not been prescribed for the reduction
or prevention of post-inflammatory
hyperpigmentation, which is a common
problem in patients with Fitzpatrick type IV or
V skin [3–5]. It has previously been shown that
herbal extracts have various effects in scar-
remodeling pathways and might have scar-
reduction properties [6, 7]. The combined
herbal extract gel (CHG) is a composition of
Allium cepa (12% w/w), Centella asiatica (5%
w/w), Aloe vera (4% w/w), Phyllanthus emblica
(1.5% w/w), and Tamarindus indica (1.5% w/w)
extract. This formulation was developed as it was
believed that their synergistic effects would help
in the prevention of scar development [8, 9].
Only one randomized control study has been
done to evaluate the efficacy of CHG in
preventing surgical scarring [9]. Thus, the
purpose of this study was to evaluate the
efficacy of the CHG in the prevention of
surgical scar formation.
METHODS
Patients aged over 18 years, who were Fitzpatrick
type III or IV skin, and had under gone bilaterally
symmetrical surgical procedures at Siriraj
Hospital (Bangkok, Thailand) were enrolled in
the study. Patients with critical illnesses (such
as systemic infections or hemodynamic
instability), major-acute illnesses, or chronic
medical illnesses that can affect wound healing
(such as bleeding disorders, transplantation,
diabetes, obesity, cancer, chronic renal failure,
and hematologic diseases) were excluded from
the study. Pregnant patients and patients with
allergic reactions to CHG were also excluded
from the study.
All patients were briefed on the study
protocol. All procedures followed were in
accordance with the ethical standards of
the responsible committee on human
experimentation (institutional and national)
and with the Helsinki Declaration of 1975, as
revised in 2000 and 2008. Informed consent was
obtained from all patients for being included in
the study.
The CHG and placebo were prepared in
identical containers. The placebo gel was a
combination of water, acrylate, C10-30 alkyl
acrylate crosspolymer, polysorbate 20, and
fragrance, and was similar in color and
consistency to that of the CHG. The
containers were labeled A or B. The identity of
the gels was kept blind to the evaluator (second
investigator) and the patients.
One week after the sutures were removed,
random cards were withdrawn for each site of
the scars to indicate which containers (A or B)
would be applied on the sites, CHG on one scar
and placebo on another scar. Application of the
gels was done twice daily, once in the morning
and once in the evening.
During each follow-up visit, the scars were
photographed and evaluated using Patient and
Observer Scar Assessment Scale (POSAS) [10–
13]. Evaluations were done on the 2nd, 4th, 8th,
and 12th week after commencing application of
the gels. The assessment consisted of the two
numeric scales: the Patient Scar Assessment
Scale (PSAS), which was completed by the
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patient, and the Observer Scar Assessment Scale
(OSAS), which was completed by one observer
[11, 14]. The median of the total score of the
POSAS was analyzed using the Wilcoxon paired
signed-rank test method. A P value of\0.05 was
considered to be statistically significant. All data
were analyzed with SPSS software (SPSS Inc.
Released 2008. SPSS Statistics for Windows,
Version 17.0. Chicago: SPSS Inc.).
RESULTS
Twenty patients with Fitzpatrick type III or IV
skin, classified as beige to beige-with-brown tint
skin color, were enrolled in this study; however,
only 17 patients completed the follow-up
period. There were 34 wounds evaluated and
analyzed. The average age of the patients was
39.44 years and ranged from 18 to 64 years.
Demographic data are shown in Table 1. Most
of the surgical procedures in our study involved
excision of nevus at both arms. The other
operations were intercostal drainage of median
sternotomy at the subcostal area (2 cases) and
mandibular osteotomy at both angles of the
chin (1 case). The dimensions of the scars
included in this study varied from 3 to 10 cm.
The CHG-treated scars showed lower PSAS
scores compared with the placebo group in
color, stiffness, thickness, irregularity, and
overall scores with statistical significance at
12 weeks’ follow-up (P value 0.03, 0.04, 0.03,
0.04, and 0.02, respectively; Figs. 1, 2). The
scores in pain and itching in the CHG group did
not significantly differ from the placebo group
at 12 weeks (P value 0.72 and 0.33,
respectively). The scars in the CHG group
showed lower OSAS scores compared with the
placebo group in pigmentation, thickness, and
overall scores at 12 weeks (P value 0.04, 0.04,
and 0.04, respectively). The OSAS scores in
vascularity, relief, and pliability in the CHG
group were significantly less than those in the
placebo group at 8 weeks (P value 0.03, 0.04,
and 0.04, respectively). No side effects were
observed in either group. The efficacy of CHG
compared to placebo gel is demonstrated in
Figs. 3 and 4.
DISCUSSION
Scarring is one factor that affects patient
satisfaction with operation results. The longest
period of wound healing is the maturation
phase [15]. In this phase, surgical scars are
hypervascularized, raised, and hard for
2–3 months after the wound has healed. The
patient will also feel itching and some pain
during this period. If we can reduce or shorten
these signs and symptoms, the patient will
benefit. Patients with Fitzpatrick type III skin
or above have a greater chance of developing
post-inflammatory hyperpigmentation,
hypertrophic scarring, and keloids than
patients with Fitzpatrick type I and II skin [3].
Many methods have been described for scar
prevention, such as pressure garments, taping,
Table 1 Demographic data
Demographic data n (%)
Sex (N = 17)
Female 13 (76)
Operation (N = 20)
Lower blepharoplasty 5 (25)




Breast surgery 2 (10)




Dermatol Ther (Heidelb) (2014) 4:187–195 189
Fig. 1 Patient Scar Assessment Scale score comparison between combined herbal extracts gel (CHG) and placebo group at
2, 4, 8, and 12 weeks’ follow-up
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Fig. 2 Observer Scar Assessment Scale score comparison between combined herbal extracts gel (CHG) and placebo group
at 2, 4, 8, and 12 weeks’ follow-up
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and silicone gel sheets/ointment [2];
however, these methods have not been
described for controlling post-inflammatory
hyperpigmentation and the other symptoms
experienced during the maturation phase.
Silicone is believed to improve scarring via
wound hydration and increased static charge
[16–18]. These mechanisms effectively decrease
the stimulation of keratinocytes, reduce
cytokine production, and inhibit excessive
collagen synthesis [18]. Silicone also helps to
rearrange the collagen fibers during the wound
healing process via the polarization between the
silicone and skin [18]. It has previously been
demonstrated that silicone has benefits in scar
reduction [18–21]. However, silicone gel sheets
may not always be appropriate in warm climates
[22]. Patients may sometimes feel sticky after
silicone therapy [22]. The silicone in a gel
preparation is easy to use when compared with
conventional silicone gel sheeting [23].
Combination of the silicone derivative with
other active compounds, such as onion extract
(which have various mechanisms), may also
have synergistic effects in scar prevention [6,
24].
Allium cepa (onion) extract, the main
component of CHG, is useful in reducing
neoangiogenesis in hypertrophic scars and
keloids, resulting in the clinical improvement
of skin vascularity [7, 24–27]. It shows an
anti-inflammatory effect by inhibiting
lipopolysaccharide-induced tumor-necrosis
factor-alpha (TNF-a) production [28]. It also
induces MMP-1 expression which has a key role
in ECM remodeling [29]. Hosnuter et al. [24]
reported that onion extract could fade scar color
and the most effective therapeutic results were
produced when it was combined with silicone
gel sheet treatment. Several scientific reports
have documented that Centella asiatica has the
ability to enhance wound healing. By treating
Fig. 3 A 30-year-old female patient underwent excision
nevus at both arms. At 8 weeks’ follow-up, PSAS for CHG
and placebo groups were 15 and 21, respectively, and
OSAS for CHG and placebo groups were 14 and 23,
respectively. At 12 weeks’ follow-up, PSAS for CHG and
placebo groups were 12 and 19, respectively, and OSAS for
CHG and placebo groups were 12 and 21, respectively.
CHG combined herbal extracts gel, OSAS Observer Scar
Assessment Scale, PSAS Patient Scar Assessment Scale
Fig. 4 A 40-year-old female patient underwent bilateral
breast reduction. At 4 weeks’ follow-up, PSAS scores for
the CHG and placebo groups were 29 and 32, respectively,
and OSAS scores for the CHG and placebo groups were
21 and 28, respectively. At 12 weeks’ follow-up, PSAS
scores for the CHG and placebo groups were 21 and 21,
respectively, and OSAS scores for the CHG and placebo
groups were 21 and 22, respectively. CHG combined
herbal extracts gel, OSAS Observer Scar Assessment Scale,
PSAS Patient Scar Assessment Scale
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with Centella asiatica extract, the maturation of
the scar is stimulated by the production of type
I collagen. The treatment also results in a
marked decrease in the inflammatory reaction
and myofibroblast production [30, 31].
Asiaticoside, the active ingredient of Centella
asiatica, has an anti-scarring effect by decreasing
the transforming growth factor beta-1
expression and enhancing the expression of
inhibitory SMAD-7 [30, 32]. Aloe vera is widely
used as a traditional herbal medicine in many
countries and is effective in the treatment of
wounds [33]. Some studies have shown that
Aloe vera extract increases the rate of healing by
enhancing keratinocyte multiplication and
migration, the expression of proliferation-
related factors, and epidermis formation [33,
34]. The study by Va´zquez et al. [35] reported
that Aloe vera could interrupt cyclooxygenase
enzyme (COX) function and decrease the
production of eicosanoid. Therefore, the
combined extracts of Allium cepa, Centella
asiatica, and Aloe vera may encourage an anti-
inflammatory effect. Tamarindus indica extract
has alkaloid, saponin, and tannin. Alkaloid is
known to assist in the epithelization of wound
and chemotaxis in fibrosis [36]. Saponin
significantly stimulates angiogenesis by
modifying the balance of protease/protease
inhibitor secretion in human endothelial
vascular cells [36–38]. Phyllanthus emblica
extract has antioxidant potentials as well as
antimicrobial activity which can be a good
therapeutic agent for accelerating the wound
healing process [39, 40]. Baek et al. [41] reported
efficacy of Phyllanthus emblica in the prevention
of hyperpigmentation by inhibiting tyrosinase
activity. Tamarindus indica extract and
Phyllanthus emblica may, therefore, have an
additive effect in reducing hyperpigmentation.
In the results of our study, the color,
stiffness, irregularity, and overall scores in
PSAS and pigmentation, thickness, and overall
scores in OSAS of the CHG study group showed
improved scores at 12 weeks. We concluded
that the CHG might improve scar formation.
The scars might have less chance to develop
post-inflammatory hyper-pigmentation. In this
study, we did not compare the CHG with any
pure silicone product. Moreover, the sample
size is quite small and there are many other
variables that may affect the outcomes. Further
studies with larger sample sizes and longer term
follow-ups are needed to confirm the benefit of
this product.
CONCLUSION
Combination of Herbal Extracts gel might be
effective in the prevention of surgical scar
formation. It has demonstrated good results,
especially in improving scar appearance and
scar hyperpigmentation.
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